Skip to main content
. 2017 Jul 31;7(7):e015905. doi: 10.1136/bmjopen-2017-015905

Figure 1.

Figure 1

Trends in prevalence of oral glucocorticoid use in France per year from 2007 to 2014. Prevalence estimates with 95% CIs (error bars) (A) overall and by sex, and (B) by age.